Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pediatric Endocrinology · Deficiency in Anterior Pituitary Function–Variable Immunodeficiency Syndrome

Standard of Care Treatment and Your Care Team

At a Glance

DAVID syndrome treatment combines daily hydrocortisone and a written plan for extra or emergency doses with individualized antibody replacement, such as IVIG or SCIG. Pediatric endocrinology and immunology teams also monitor infections, vaccines, growth, and other pituitary hormones.

Because DAVID syndrome affects both the immune and endocrine systems, managing it requires a coordinated approach. While the combination of these conditions is rare, the treatments for each part—adrenal insufficiency and antibody deficiency—are well-established and effective [1][2].

Endocrine Management: Replacing Cortisol

The hallmark of the endocrine side of DAVID syndrome is ACTH deficiency, which means the body cannot make enough cortisol (the “stress hormone”). This causes central (secondary) adrenal insufficiency. While central adrenal insufficiency usually does not affect the salt-regulating hormone aldosterone like primary adrenal insufficiency does, this does not lessen the risk of a life-threatening adrenal crisis.

  • Daily Replacement: The standard treatment is daily hydrocortisone, a short-acting medication that replaces what the body is missing [3]. Because cortisol levels naturally fluctuate throughout the day, the dose is usually divided into two or three parts [4].
  • Stress Dosing: During times of “physiological stress”—such as a fever, a serious illness, or surgery—the body requires more cortisol. You must manually increase the dose according to a specific, written Adrenal Insufficiency Action Plan provided by your endocrinologist [5][6].
  • Emergency Injection: If your child is vomiting and cannot keep their oral medication down, or if they show signs of an adrenal crisis, an immediate intramuscular (IM) injection of hydrocortisone is required to save their life [7][8]. Your written plan will specify exactly when and how to use this.

Immunology Management: Boosting Defenses

To address the hypogammaglobulinemia (low antibodies), the goal is to provide the immune “armor” your child’s body isn’t building.

  • Immunoglobulin Replacement Therapy (IgRT): This involves regular infusions of antibodies (IgG) collected from healthy donors.
    • IVIG (Intravenous): Given through a vein, usually once every 3 to 4 weeks in a clinic or hospital [9].
    • SCIG (Subcutaneous): Given under the skin, often weekly. This can frequently be done at home by parents after training [9][10].
  • Antibiotic Prophylaxis: For some children who continue to have infections despite immunoglobulin therapy, doctors may prescribe a low-dose “preventative” antibiotic to take daily [11][12].
  • Monitoring: Your immunologist will monitor “trough levels” (the lowest level of IgG in the blood before the next dose) and adjust the amount based on how well your child is fighting off infections [13][14]. Note that not every child with NFKB2-related antibody dysfunction needs IgRT; decisions are highly individualized.

Vaccines and Immunizations

Vaccine management requires a patient-specific plan from your immunologist.

  • Inactivated Vaccines: These are generally recommended, though the body’s antibody response to them may be reduced [15].
  • Live Vaccines: Live-virus vaccines (like MMR or Varicella) may be contraindicated or require individualized review by the immunology team.
  • IgRT Interference: If your child receives IVIG/SCIG, the donor antibodies can interfere with the timing and interpretation of some live-virus vaccines.
  • Never start, stop, or defer vaccines based solely on this guide. Always obtain a formal vaccine plan from your immunologist.

Comprehensive Pituitary Care

The NFKB2 mutation can sometimes affect other hormones over time.

  • Growth and Thyroid: While ACTH is the most common deficiency in DAVID syndrome, some children also develop Growth Hormone (GH) or Thyroid-Stimulating Hormone (TSH) deficiencies [1][15].
  • Sequential Testing: Because these issues can emerge years after the initial diagnosis, your care team will perform regular blood work and monitor your child’s growth charts closely [16].

Building and Vetting Your Care Team

Your child’s “medical home” should be anchored by a Pediatric Endocrinologist and a Pediatric Immunologist who are willing to talk to each other. Because infections (the domain of the immunologist) trigger the need for stress dosing (the domain of the endocrinologist), these two specialists must be in sync.

When meeting with specialists, consider asking:

  1. “How many patients with adrenal insufficiency or CVID do you currently manage?”
  2. “What is your preferred method for communicating with the other specialists on my child’s team?”
  3. “Can you provide a written, customized Adrenal Action Plan that specifically addresses how to handle infections and vomiting?” [8]

A Genetic Counselor is also a vital team member to help you understand the NFKB2 mutation and what it means for other family members [17]. Coordinating this “village” of specialists ensures that both the immune and hormone systems are protected simultaneously.

Common questions in this guide

What is the main treatment for DAVID syndrome?
The endocrine problem is treated with daily hydrocortisone to replace cortisol that the body cannot make. Low antibody levels may be treated with immunoglobulin replacement, such as IVIG or SCIG, and some children with ongoing infections may receive preventive antibiotics.
When does a child with DAVID syndrome need extra hydrocortisone?
Fever, serious illness, surgery, and other physical stress can increase the body's need for cortisol. The endocrinologist should provide a written action plan explaining how to increase oral hydrocortisone and when to use emergency treatment.
What should I do if my child vomits after taking hydrocortisone?
If your child cannot keep oral hydrocortisone down, follow the written adrenal action plan and give the prescribed intramuscular hydrocortisone injection when instructed. Seek urgent medical help, because vomiting during adrenal insufficiency can lead to a life-threatening adrenal crisis.
How do IVIG and SCIG differ for DAVID syndrome?
IVIG delivers donor antibodies through a vein, usually every three to four weeks in a clinic or hospital. SCIG delivers antibodies under the skin, often weekly, and may be given at home after caregiver training; the best option depends on the child's medical needs and family preferences.
Can children with DAVID syndrome receive vaccines?
Inactivated vaccines are generally recommended, although the antibody response may be reduced. Live vaccines require individualized review, and immunoglobulin therapy can affect the timing or interpretation of some live-virus vaccines, so the immunologist should create the vaccine plan.
Which specialists should manage a child with DAVID syndrome?
A pediatric endocrinologist and pediatric immunologist should coordinate care because infections can trigger the need for hydrocortisone stress dosing. A genetic counselor can explain the NFKB2 mutation and its implications for family members, while the team monitors growth, thyroid function, and other pituitary hormones.
Could DAVID syndrome cause other hormone problems later?
Yes. Some children develop growth hormone or thyroid-stimulating hormone deficiencies after the initial diagnosis, so the care team may repeat blood tests and review growth charts over time. The timing of monitoring should be individualized by the child's endocrinologist.

Get notified when new evidence is published on Deficiency in anterior pituitary function-variable immunodeficiency syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports.

    Mac TT, Castinetti F, Bar C, et al.

    Journal of neuroendocrinology 2023; (35(6)):e13287 doi:10.1111/jne.13287.

    PMID: 37322808
  2. 2

    Symptomatic hypoglycemia in a child with common variable immunodeficiency: Deficient anterior pituitary with variable immune deficiency (DAVID) syndrome.

    Nogueira M, Pinheiro M, Maia R, et al.

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2020; (29(3)):111-113 doi:10.1297/cpe.29.111.

    PMID: 32694887
  3. 3

    Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment.

    Ceccato F, Scaroni C

    Clinical chemistry and laboratory medicine 2019; (57(8)):1125-1135.

    PMID: 30427776
  4. 4

    Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

    Bornstein SR, Allolio B, Arlt W, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(2)):364-89 doi:10.1210/jc.2015-1710.

    PMID: 26760044
  5. 5

    Emergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidance.

    Mushtaq T, Ali SR, Boulos N, et al.

    Archives of disease in childhood 2023; (108(11)):871-878 doi:10.1136/archdischild-2022-325156.

    PMID: 37045585
  6. 6

    Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK.

    Woodcock T, Barker P, Daniel S, et al.

    Anaesthesia 2020; (75(5)):654-663 doi:10.1111/anae.14963.

    PMID: 32017012
  7. 7

    Treatment and Prevention of Adrenal Crisis and Family Education

    Çamtosun E, Sangün Ö

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):80-92 doi:10.4274/jcrpe.galenos.2024.2024-6-12-S.

    PMID: 39713905
  8. 8

    Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.

    Miller BS, Spencer SP, Geffner ME, et al.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2020; (68(1)):16-25 doi:10.1136/jim-2019-000999.

    PMID: 30819831
  9. 9

    New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients.

    Krivan G, Jolles S, Granados EL, et al.

    American journal of clinical and experimental immunology 2017; (6(5)):76-83.

    PMID: 29181272
  10. 10

    A clinician's guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.

    Epland K, Suez D, Paris K

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):87 doi:10.1186/s13223-022-00726-7.

    PMID: 36180928
  11. 11

    Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.

    Hanitsch L, Baumann U, Boztug K, et al.

    European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.

    PMID: 32845010
  12. 12

    Primary Immunodeficiency: Specific antibody deficiency with normal IgG.

    Hatcher VR, Alix VC, Hellu TS, Schuldt MM

    Allergy and asthma proceedings 2024; (45(5)):321-325 doi:10.2500/aap.2024.45.240057.

    PMID: 39294904
  13. 13

    Immunoglobulin therapies for primary immunodeficiency diseases (part 2): considerations for dosing strategies.

    Li Z, Mahmood I

    Immunotherapy 2024; (16(13)):895-905 doi:10.1080/1750743X.2024.2382074.

    PMID: 39323406
  14. 14

    Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects.

    Matucci A, Maggi E, Vultaggio A

    Frontiers in immunology 2014; (5()):690 doi:10.3389/fimmu.2014.00690.

    PMID: 25628625
  15. 15

    A Case Report of Hypoglycemia and Hypogammaglobulinemia: DAVID Syndrome in a Patient With a Novel NFKB2 Mutation.

    Lal RA, Bachrach LK, Hoffman AR, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(7)):2127-2130 doi:10.1210/jc.2017-00341.

    PMID: 28472507
  16. 16

    Central Diabetes Insipidus in a Patient With NFKB2 Mutation: Expanding the Endocrine Phenotype in DAVID Syndrome.

    Nasomyont N, Lindsley AW, Assa'ad A, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(9)):4051-4057 doi:10.1210/jc.2019-00469.

    PMID: 31150062
  17. 17

    Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies.

    Sjøgren T, Bratland E, Røyrvik EC, et al.

    Journal of autoimmunity 2022; (133()):102917 doi:10.1016/j.jaut.2022.102917.

    PMID: 36191466

This page is for informational purposes only and does not constitute medical advice. Your child's endocrinologist and immunologist must provide individualized dosing, vaccine, and immunoglobulin instructions, and suspected adrenal crisis requires urgent medical care.